Gujarat

NIPER Ahmedabad was initiated with three specializations Biotechnology, Natural Products and Pharmaceutics and over the period of time three more specializations Pharmaceutical Analysis, Medicinal Chemistry and Pharmacology and Toxicology were added in 2010. Subsequently in 2011, to cater the needs of Medical device industry in India, another feather was added to the cap of NIPER Ahmedabad in the form of specialization in Medical Devices.

Post : Project Research Scientist -I (Non-Medical) in ICMR funded project

After a journey of growth spanning 27 years as Cadila Healthcare Ltd. and the Zydus Group, we have evolved and transformed ourselves in response to the changing times. Our legacy of over 70 years in healthcare and being dedicated to life in all its dimensions is reaffirmed in our new mission, vision and purpose. Unifying ourselves under the Zydus name, Cadila Healthcare Ltd., is renamed as Zydus Lifesciences Ltd.

Post : Research Scientist

Accuprec Research Labs Pvt Ltd. is FDCA approved, OECD-GLP, NABL accredited and ISO 9001:2015 certified CRO. Head Quarter of the CRO is located at Ahmedabad and branch offices at Canada and USA. Accuprec provides all type of Pharmaceutical testing solutions to its domestic and MNC clients. Accuprec requires below mentioned staff.

NIPER Ahmedabad was initiated with three specializations Biotechnology, Natural Products and Pharmaceutics and over the period of time three more specializations Pharmaceutical Analysis, Medicinal Chemistry and Pharmacology and Toxicology were added in 2010. Subsequently in 2011, to cater the needs of Medical device industry in India, another feather was added to the cap of NIPER Ahmedabad in the form of specialization in Medical Devices.

Post : Research Associate (RA) (one position only)

NIPER Ahmedabad was initiated with three specializations Biotechnology, Natural Products and Pharmaceutics and over the period of time three more specializations Pharmaceutical Analysis, Medicinal Chemistry and Pharmacology and Toxicology were added in 2010. Subsequently in 2011, to cater the needs of Medical device industry in India, another feather was added to the cap of NIPER Ahmedabad in the form of specialization in Medical Devices.

Post : Senior Research Fellow

CSMCRI with much scientific excitement has now achieved technological excellence with several granted patents in the core mandate of the institute and is one among the top performing national R&D laboratories in the country. At the beginning of 2011, the Institute has around 360 staff with 150 S&T staff on its roll and around 250 research fellows and project assistants pursing their doctoral programme.

The JAMP group is a proud Canadian owned company with its international headquarters located in Boucherville, 20 minutes from downtown Montreal, Quebec, Canada. The JAMP Pharma Group is active in all sectors of the pharmaceutical industry with our JAMP Pharma Generics, Orimed branded products, our Wampole and Laboratoire Suisse natural health supplements and our Cosmetic Import beauty and personal care products. The JAMP Pharma Group has also made a major investment in biosimilars which is one of the fastest growing markets in the pharmaceutical industry.

RK Pharma Inc. Is a privately held US based company that focuses on the development, manufacturing and commerclaliiation of high quality and affordable generic pharmaceutical products. Our core competency is Research & Complex Chemistry. Our mission is to develop, manufacture and deliver API's, with superior quolity and regulatory support, at competitive costs.

Nirma University, Ahmedabad has been established in the year 2003 as a statutory university under the Gujarat State Act by the initiative of the Nirma Education & Research Foundation (NERF). The University is a value-driven, research-oriented and student-centered not-for-profit state private university.  The University and its constituent institute are highly ranked by different ranking agencies. The University is recognized by the University Grants Commission (UGC) under section 2(f) of the UGC Act.